收费全文 | 9746篇 |
免费 | 570篇 |
国内免费 | 25篇 |
耳鼻咽喉 | 134篇 |
儿科学 | 474篇 |
妇产科学 | 130篇 |
基础医学 | 1084篇 |
口腔科学 | 165篇 |
临床医学 | 744篇 |
内科学 | 2008篇 |
皮肤病学 | 178篇 |
神经病学 | 665篇 |
特种医学 | 250篇 |
外科学 | 1647篇 |
综合类 | 190篇 |
一般理论 | 4篇 |
预防医学 | 565篇 |
眼科学 | 470篇 |
药学 | 967篇 |
中国医学 | 43篇 |
肿瘤学 | 623篇 |
2023年 | 81篇 |
2022年 | 180篇 |
2021年 | 404篇 |
2020年 | 213篇 |
2019年 | 260篇 |
2018年 | 347篇 |
2017年 | 234篇 |
2016年 | 293篇 |
2015年 | 303篇 |
2014年 | 399篇 |
2013年 | 476篇 |
2012年 | 694篇 |
2011年 | 698篇 |
2010年 | 392篇 |
2009年 | 351篇 |
2008年 | 545篇 |
2007年 | 597篇 |
2006年 | 586篇 |
2005年 | 474篇 |
2004年 | 431篇 |
2003年 | 401篇 |
2002年 | 357篇 |
2001年 | 210篇 |
2000年 | 161篇 |
1999年 | 123篇 |
1998年 | 81篇 |
1997年 | 52篇 |
1996年 | 78篇 |
1995年 | 32篇 |
1994年 | 28篇 |
1993年 | 36篇 |
1992年 | 56篇 |
1991年 | 60篇 |
1990年 | 61篇 |
1989年 | 70篇 |
1988年 | 74篇 |
1987年 | 67篇 |
1986年 | 51篇 |
1985年 | 43篇 |
1984年 | 44篇 |
1983年 | 32篇 |
1982年 | 23篇 |
1981年 | 20篇 |
1980年 | 26篇 |
1979年 | 26篇 |
1977年 | 22篇 |
1975年 | 18篇 |
1973年 | 17篇 |
1971年 | 15篇 |
1970年 | 26篇 |
Background
The optimal noninvasive test (NIT) for patients with diabetes and stable symptoms of coronary artery disease (CAD) is unknown.Objectives
The purpose of this study was to assess whether a diagnostic strategy based on coronary computed tomographic angiography (CTA) is superior to functional stress testing in reducing adverse cardiovascular (CV) outcomes (CV death or myocardial infarction [MI]) among symptomatic patients with diabetes.Methods
PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) was a randomized trial evaluating an initial strategy of CTA versus functional testing in stable outpatients with symptoms suggestive of CAD. The study compared CV outcomes in patients with diabetes (n = 1,908 [21%]) and without diabetes (n = 7,058 [79%]) based on their randomization to CTA or functional testing.Results
Patients with diabetes (vs. without) were similar in age (median 61 years vs. 60 years) and sex (female 54% vs. 52%) but had a greater burden of CV comorbidities. Patients with diabetes who underwent CTA had a lower risk of CV death/MI compared with functional stress testing (CTA: 1.1% [10 of 936] vs. stress testing: 2.6% [25 of 972]; adjusted hazard ratio: 0.38; 95% confidence interval: 0.18 to 0.79; p = 0.01). There was no significant difference in nondiabetic patients (CTA: 1.4% [50 of 3,564] vs. stress testing: 1.3% [45 of 3,494]; adjusted hazard ratio: 1.03; 95% confidence interval: 0.69 to 1.54; p = 0.887; interaction term for diabetes p value = 0.02).Conclusions
In diabetic patients presenting with stable chest pain, a CTA strategy resulted in fewer adverse CV outcomes than a functional testing strategy. CTA may be considered as the initial diagnostic strategy in this subgroup. (PROspective Multicenter Imaging Study for Evaluation of Chest Pain [PROMISE]; NCT01174550) 相似文献2. The CGA is administered intravenously (IV) and intranasally (IN) at the dose of 10?mg/kg. Further, its concentration in the plasma, cerebrospinal fluid (CSF) and the whole brain is analyzed by HPLC-UV method.
3. The study observes that CGA is rapidly absorbed in plasma with tmax of 1?min similar to IV route after IN administration. The peak plasma concentration and AUC0–24 are higher by 3.5 and 4.0 times respectively in IV administration, compared to IN delivery that represents the significant less systemic exposure of CGA in IN route.
4. However, the concentration of CGA in the brain is 4, 6.5, 5.3, 5.2 and 4.5 times higher at 30, 60, 120, 240 and 360?min, respectively in IN administration compared to IV administration. The exposure of CGA in the brain after IN administration (AUCbrain, IN) was significantly greater (4 times) as compared to the exposure of CGA in the brain (AUCbrain, IV) after IV administration reflecting significant brain uptake of CGA through nasal route. Therefore, IN delivery of CGA can be a promising approach for the treatment of stroke and neurodegenerative disorders. 相似文献